Delivery Order SPE2DB22D1017-SPE2DB24FE8AP
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,640.00, is a Delivery Order under DLA's Indefinite Delivery Contract (IDC) with AmerisourceBergen, which has a ceiling of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Prograf 1 mg capsules. The contract has a total ceiling value of $2,159.02 and a performance period through December 27, 2023. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,431.75 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order (SPE2DB25FZ14B) valued at $25,634.40 for the supply of PROGRAF 1 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 20, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,394.15 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a medication used in organ transplant patients. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,252.35 firm fixed-price delivery order is for the supply of PROGRAF 5 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,484.39 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a medical product, with a period of performance through May 31, 2024. The contract was not set aside for any specific socioeconomic category. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $5,076.81 firm fixed price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award, with the ID SPE2DB20D2014|SPE2DB24FD09U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Prograf 1 mg capsules, a pharmaceutical product, with a ceiling value of $3,622.20. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of September 23, 2024. This award does not have a set-aside...
- This federal contract award, valued at $13,925.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a completion date of October 24, 2024. The contract is structured as a Delivery Order under a Firm Fixed Price pricing type. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE8APDelivery Order
This federal contract award is for the delivery of Prograf 1 mg capsules to the Defense Logistics Agency (DLA). The $11,361.06 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 11/6/23 |